ZA975416B - Novel compounds - Google Patents

Novel compounds

Info

Publication number
ZA975416B
ZA975416B ZA975416A ZA975416A ZA975416B ZA 975416 B ZA975416 B ZA 975416B ZA 975416 A ZA975416 A ZA 975416A ZA 975416 A ZA975416 A ZA 975416A ZA 975416 B ZA975416 B ZA 975416B
Authority
ZA
South Africa
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
ZA975416A
Other languages
English (en)
Inventor
Steven Mark Bromidge
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA975416B publication Critical patent/ZA975416B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ZA975416A 1996-06-20 1997-06-19 Novel compounds ZA975416B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612885.5A GB9612885D0 (en) 1996-06-20 1996-06-20 Novel compounds

Publications (1)

Publication Number Publication Date
ZA975416B true ZA975416B (en) 1999-01-25

Family

ID=10795577

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975416A ZA975416B (en) 1996-06-20 1997-06-19 Novel compounds

Country Status (27)

Country Link
US (2) US6313145B1 (pl)
EP (1) EP0912556B1 (pl)
JP (1) JP2000512644A (pl)
KR (1) KR20040101563A (pl)
CN (1) CN1147485C (pl)
AR (1) AR008244A1 (pl)
AT (1) ATE196766T1 (pl)
AU (1) AU718000B2 (pl)
BR (1) BR9709982A (pl)
CA (1) CA2258559A1 (pl)
CO (1) CO4870758A1 (pl)
CZ (1) CZ289799B6 (pl)
DE (1) DE69703242T2 (pl)
DK (1) DK0912556T3 (pl)
ES (1) ES2152682T3 (pl)
GB (1) GB9612885D0 (pl)
GR (1) GR3034847T3 (pl)
HU (1) HUP9903480A3 (pl)
IL (1) IL127304A (pl)
NO (1) NO316756B1 (pl)
NZ (1) NZ332840A (pl)
PL (1) PL186885B1 (pl)
PT (1) PT912556E (pl)
TR (1) TR199802552T2 (pl)
TW (1) TW360650B (pl)
WO (1) WO1997048700A1 (pl)
ZA (1) ZA975416B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710523D0 (en) * 1997-05-23 1997-07-16 Smithkline Beecham Plc Novel compounds
WO1999043650A2 (en) * 1998-02-25 1999-09-02 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
US20030008880A1 (en) * 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
JP2005535560A (ja) 2001-11-28 2005-11-24 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 治療用の化合物
GB0200283D0 (en) * 2002-01-08 2002-02-20 Smithkline Beecham Plc Compounds
MXPA04008517A (es) 2002-03-04 2005-08-19 Pharmacia & Upjohn Co Llc Compuestos terapeuticos.
ATE423094T1 (de) * 2002-04-19 2009-03-15 Glaxo Group Ltd Verbindungen mit affinität zum 5ht2c-rezeptor und deren therapeutische verwendung
GB0305024D0 (en) * 2003-03-05 2003-04-09 Glaxo Group Ltd Compounds
GB0305553D0 (en) * 2003-03-11 2003-04-16 Glaxo Group Ltd Compounds
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
CN102348798A (zh) 2009-01-16 2012-02-08 麻省理工学院 孤独症谱系障碍的诊断和治疗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2142721A1 (en) 1992-08-20 1994-03-03 Ian T. Forbes Condensed indole derivatives as 5ht and 5ht antagonists
GB9313913D0 (en) 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
WO1996023769A2 (en) 1995-02-02 1996-08-08 Smithkline Beecham Plc Heterocyclic compounds possessing 5ht2c receptor antagonist activity
NZ301265A (en) * 1995-02-02 1998-12-23 Smithkline Beecham Plc Indole derivatives as 5ht receptor antagonists, preparation and pharmaceutical compositions thereof
GB9607219D0 (en) 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP

Also Published As

Publication number Publication date
US6313145B1 (en) 2001-11-06
NO985970D0 (no) 1998-12-18
GB9612885D0 (en) 1996-08-21
US20020035134A1 (en) 2002-03-21
EP0912556B1 (en) 2000-10-04
CO4870758A1 (es) 1999-12-27
NO985970L (no) 1998-12-18
GR3034847T3 (en) 2001-02-28
CZ420498A3 (cs) 1999-05-12
BR9709982A (pt) 1999-08-10
AU3339697A (en) 1998-01-07
NZ332840A (en) 2000-05-26
AU718000B2 (en) 2000-04-06
DE69703242T2 (de) 2001-03-08
HUP9903480A3 (en) 2002-12-28
JP2000512644A (ja) 2000-09-26
ES2152682T3 (es) 2001-02-01
NO316756B1 (no) 2004-04-26
CZ289799B6 (cs) 2002-04-17
EP0912556A1 (en) 1999-05-06
PT912556E (pt) 2001-02-28
KR20040101563A (ko) 2004-12-02
DK0912556T3 (da) 2001-01-22
DE69703242D1 (de) 2000-11-09
AR008244A1 (es) 1999-12-29
HUP9903480A2 (en) 2000-07-28
CA2258559A1 (en) 1997-12-24
IL127304A (en) 2003-07-06
WO1997048700A1 (en) 1997-12-24
CN1147485C (zh) 2004-04-28
PL186885B1 (pl) 2004-03-31
TW360650B (en) 1999-06-11
HK1019744A1 (en) 2000-02-25
ATE196766T1 (de) 2000-10-15
TR199802552T2 (xx) 1999-02-22
CN1222152A (zh) 1999-07-07
PL330708A1 (en) 1999-05-24
IL127304A0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
EP0961618A4 (en) NEW COMPOUNDS
EP0909181A4 (en) NEW COMPOUNDS
GB9601067D0 (en) Novel compounds
EP0907376A4 (en) NEW CONNECTIONS
AP9701047A0 (en) Novel compounds
GB9605945D0 (en) Novel compounds
GB9612885D0 (en) Novel compounds
GB9600955D0 (en) Novel compounds
GB9604045D0 (en) Novel compounds
GB9601041D0 (en) Novel compounds
AP9701037A0 (en) Novel compounds
GB9605883D0 (en) Novel compounds
GB9601069D0 (en) Novel compounds
EP0954525A4 (en) NEW CONNECTIONS
GB9601068D0 (en) Novel compounds
GB9601099D0 (en) Novel compounds
GB9606208D0 (en) Novel compounds
GB9603655D0 (en) Novel compounds
GB9602679D0 (en) Novel compounds
GB9606518D0 (en) Novel compounds
GB9605495D0 (en) Novel compounds
GB9606198D0 (en) Novel compounds
GB9605154D0 (en) Novel compounds
GB9605865D0 (en) Novel compounds
GB9606649D0 (en) Novel compounds